Jessica M Newblom

Title: Jessica M Newblom: Innovator in Signaling Modulation

Introduction

Jessica M Newblom is a prominent inventor based in Indianapolis, IN (US). She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that modulate cellular signaling pathways. With a total of 4 patents to her name, her work has the potential to impact therapeutic methods for various diseases.

Latest Patents

Among her latest patents, one notable invention is related to heterocyclic compound classes for signaling modulation. This invention involves compounds of Formulas I-VII, which are designed to modulate cellular signaling pathways and biological processes. It specifically addresses the inhibition of kinase activity, such as PI-3 kinase, and bromodomain proteins, offering therapeutic methods for treating diseases associated with these proteins. Another significant patent focuses on thienopyranones as kinase inhibitors, which also aims to inhibit kinase activity, particularly PI-3 kinase.

Career Highlights

Jessica has worked with reputable companies in the pharmaceutical industry, including Signal Pharmaceuticals, Inc. and SignalRx Pharmaceuticals, Inc. Her experience in these organizations has allowed her to develop and refine her innovative ideas, contributing to advancements in drug development.

Collaborations

Throughout her career, Jessica has collaborated with notable professionals in her field, including Guillermo A Morales and Kevin T Weber. These collaborations have likely enriched her research and contributed to her success as an inventor.

Conclusion

Jessica M Newblom is a distinguished inventor whose work in signaling modulation has the potential to lead to significant advancements in therapeutic methods. Her contributions to the field are noteworthy, and her patents reflect her innovative spirit and dedication to improving healthcare.